These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2195493
1. High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution. Strickley RG, Brandl M, Chan KW, Straub K, Gu L. Pharm Res; 1990 May; 7(5):530-6. PubMed ID: 2195493 [Abstract] [Full Text] [Related]
2. Stability of ricobendazole in aqueous solutions. Wu Z, Tucker IG, Razzak M, Medlicott NJ. J Pharm Biomed Anal; 2009 Jul 12; 49(5):1282-6. PubMed ID: 19342190 [Abstract] [Full Text] [Related]
3. Degradation kinetics of gonadorelin in aqueous solution. Hoitink MA, Beijnen JH, Bult A, van der Houwen OA, Nijholt J, Underberg WJ. J Pharm Sci; 1996 Oct 12; 85(10):1053-9. PubMed ID: 8897270 [Abstract] [Full Text] [Related]
4. Stability of new potential ACE inhibitor in the aqueous solutions of different pH. Roskar R, Simoncic Z, Gartner A, Kmetec V. J Pharm Biomed Anal; 2009 Feb 20; 49(2):295-303. PubMed ID: 19135817 [Abstract] [Full Text] [Related]
5. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor. Denora N, Potts BC, Stella VJ. J Pharm Sci; 2007 Aug 20; 96(8):2037-47. PubMed ID: 17554770 [Abstract] [Full Text] [Related]
6. Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Skidgel RA, Erdös EG. Proc Natl Acad Sci U S A; 1985 Feb 20; 82(4):1025-9. PubMed ID: 2983326 [Abstract] [Full Text] [Related]
7. Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution. Powell MF, Sanders LM, Rogerson A, Si V. Pharm Res; 1991 Oct 20; 8(10):1258-63. PubMed ID: 1839059 [Abstract] [Full Text] [Related]
8. Characterization of the solution degradation products of histrelin, a gonadotropin releasing hormone (LH/RH) agonist. Oyler AR, Naldi RE, Lloyd JR, Graden DA, Shaw CJ, Cotter ML. J Pharm Sci; 1991 Mar 20; 80(3):271-5. PubMed ID: 2051345 [Abstract] [Full Text] [Related]
9. Stability and degradation profiles of Spantide II in aqueous solutions. Kikwai L, Babu RJ, Kanikkannan N, Singh M. Eur J Pharm Sci; 2006 Feb 20; 27(2-3):158-66. PubMed ID: 16266798 [Abstract] [Full Text] [Related]
10. Characterization of the degradation products of luteinizing hormone releasing hormone. Motto MG, Hamburg PF, Graden DA, Shaw CJ, Cotter ML. J Pharm Sci; 1991 May 20; 80(5):419-23. PubMed ID: 1880718 [Abstract] [Full Text] [Related]
11. The aqueous stability of bupropion. O'Byrne PM, Williams R, Walsh JJ, Gilmer JF. J Pharm Biomed Anal; 2010 Nov 02; 53(3):376-81. PubMed ID: 20547024 [Abstract] [Full Text] [Related]
12. Preformulation stability studies of the new dipeptide angiotensin-converting enzyme inhibitor RS-10029. Gu L, Strickley RG. Pharm Res; 1988 Dec 02; 5(12):765-71. PubMed ID: 3247286 [Abstract] [Full Text] [Related]
13. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH. Kenley RA, Tracht S, Stepanenko A, Townsend M, L'Italien J. AAPS PharmSciTech; 2000 Mar 18; 1(2):E7. PubMed ID: 14727840 [Abstract] [Full Text] [Related]
20. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Strickley RG, Anderson BD. Pharm Res; 1996 Aug 18; 13(8):1142-53. PubMed ID: 8865303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]